Hemoglobin concentrations are closely linked to renal function in patients with type 1 or 2 diabetes mellitus

Kidney and Blood Pressure Research

Volumn 31, Issue 5, 2008, Pages 313-321

  Wolf, Gunter ^a,b   Müller, Nicolle ^a   Hunger Battefeld, Wilgard ^a   Kloos, Christof ^a   Müller, Ulrich A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Anemia; Diabetes mellitus, type 1 and 2; Diabetic nephropathy; Metabolic control

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ANEMIA; ARTICLE; CHILD; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 51349103436     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155230     Document Type: Article

References (28)

1. Al-Khoury S, Afzali B, Shah N, Thomas S, Gusbeth-Tatomir P, Goldsmith D, Covic A: Diabetes, kidney disease and anaemia: time to tackle a troublesome triad? Int J Clin Prac 2007,61:281-289.
2. Shu DH, Ransom TPP, O'Connell CM, Cox JL, Kaiser SM, Gee SA, Rowe RC, Ur E, Imran SA: Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovas Diabetol 2006;5:8-17.
3. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG: Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure. Circulation 2006;113:2713-2723.
4. Ritz E, Haxsen V: Diabetic nephropathy and anaemia. Eur J Clin Invest 2005;35(suppl 3):66-74.
5. Babazono T, Hanai K, Suzuki K, Kluchi Y, Inoue A, Tanaka M, Tanaka N, Hase M, Ishii A, Iwamoto Y: Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia 2006;49:1387-1393.
6. Rossert J, Levin A, Roger SD, Hörl WH, Fouqueray B, Gassmann-Mayer C, Frei D, McCellan WM: Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 2006;47:738-750.
7. Al-Khoury S, Afzali B, Shah N, Covic A, Thomas S, Goldsmith DJ: Anaemia in diabetic patients with chronic kidney disease: prevalence and predictors. Diabetologia 2006;49:1183-1189.
8. Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G: Unrecognized anemia in patients with diabetes. Diabetes Care 2003;26:1164-1169.
9. Ravanan R, Spiro JR, Matheison PW, Smith RN: Impact of diabetes on haemoglobin levels in renal disease. Diabetologia 2007;50:26-31.
10. McGill JB, Bell DSH: Anemia and the role of erythropoietin in diabetes. J Diabetes Complications 2006;20:262-272.
11. Tong PCY, Kong APS, So W, Ng MHL, Yang X, Ng MCY, Ma RCW, Ho CS, Lam CWK, Chow CC, Cockram CS, Chan JCN: Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2006;29:2439-2444.
12. Bosman DR, Winkler AS, Marsden JT, MacDougall IC, Watkins PJ: Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001;24:495-499.
13. Bruno CM, Sciacca C, Bertino G, Cilio D, Pellicano R, Marchese AE, Politi G, Chinnici L: Circulating erythropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study. J Diabetes Complications 2006;20:376-379.
14. Thomas MC, Tsalamandris C, MacIsaac RJ, Jerums G: The epidemiology of hemoglobin levels in patients with type 2 diabetes. Am J Kidney Dis 2006;48:537-545.
15. Hasslacher C, Kempe P, Ritz E, Wolf G: Praxisleitlinie: diabetische Nephropathie. Diabet Stoffwechsel 2007;2(suppl 2):S159-S162.
16. Levey AS, Bosch JP, Breyer-Lewis J, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new equation. Ann Intern Med 1999;130:461-470.
17. Müller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jorgens V, Berger M, Muhlhauser I: Intensified treatment and education of type 1 diabetes as clinical routine: a nationwide quality-circle experience in Germany. ASD (the working groups on structured diabetes therapy of the German diabetes association). Diabetes Care 1999;22(suppl 2):B29-B34.
18. Sasso FC, De Nicola L, Nasti R, Minutolo R, Salvatore T, Conte G, Torella R: Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy. Diabetes Care 2006;29:498-503.
19. Thomas MC, MacIsaac RJ, Tsalamandris C, Molyneaux L, Goubina I, Fulcher G, Yue D, Jerums G: Anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2004;89:4359-4363.
20. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, Shino T, Yamada C, Nagaoka Y: Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998;37:826-830.
21. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903.
22. Van der Meer P, Lipsic E, Westenbrink D, van der Wal RMA, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH: Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 2005;112:1743-1747.
23. Schiffl H, Lang SM: Angiotensin-converting inhibitors but not angiotensin II AT1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease. Nephron 1999;81:106-108.
24. Piccoli A, Pastori G, Perobon E, Torraca S, Andreucci M, Sabbatini M, Cianciaruso B: Anti-renin-angiotensin-system drugs and development of anemia in chronic kidney disease. J Nephrol 2005;18:585-591.
25. Stenvinkel P: Anaemia and inflammation: what are the implications for the nephrologist? Nephrol Dial Transplant 2003;18(suppl 8):VIII7-VIII22.
26. Weiss G, Goodnough LT: Anemia of chronic disease. N Eng J Med 2005;352:1011-1023.
27. Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA: Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007;27:322-328.
28. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999;56:1627-1637.